Menu

Linoleic Acid Derivatives Potentially Mediate Pain and Itch in the Skin

Researchers uncover a family of compounds that may be involved in pain transmission.

Jan 1, 2018
Katarina Zimmer

OMEGA-6 FIELDS: Linoleic acid is plentiful in soy and other common components of modern Western diets.© ISTOCK.COM/SCALATORE1959

EDITOR'S CHOICE IN CELL AND MOLECULAR BIOLOGY

The paper
C.E. Ramsden et al., “A systems approach for discovering linoleic acid derivatives that potentially mediate pain and itch,” Sci Signal, doi:10.1126/scisignal.aal5241, 2017.

Pluses and Minuses
Linoleic acid, also known as omega-6 fatty acid—abundant in many vegetable and seed oils—is essential for forming our skin’s waxy, waterproof barrier, and has become an increasingly common component of modern Western diets. Research has linked it to pain and chronic headaches, and Christopher Ramsden, a nutrition researcher at the National Institute on Aging, wanted to know why.

Scratching the Itch
Ramsden and colleagues explored eight linoleic acid derivatives in human and rat skin. They prospected for the compounds in inflamed psoriatic skin lesions in humans, and injected them into mice to see if they would induce itching.

Feeling Pain
One of the derivatives was significantly more concentrated in psoriatic skin than in healthy skin, and induced scratching in mice. Two of the other compounds sensitized rat sensory neurons in vitro, supporting the hypothesis that such molecules could spark pain sensations. “That’s the first step in feeling itch or pain,” explains Ramsden. In line with this, when the researchers analyzed data from a clinical trial that had tested strategies to manage chronic headache, they found that patients reported fewer painful episodes when they cut back their intake of linoleic acid.

Molecular Mystery
The receptors that bind these derivatives, once identified, might provide novel pharmacological targets for treating pain. Tamara Rosenbaum, who studies pain at the National Autonomous University of Mexico and who was not involved in the study, tells The Scientist in an email that a lot of work is still needed to understand the molecular mechanisms at play, but that the study “provides us with important pieces to a puzzle.”

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!